Evidence map›Paper›PMID 41976403›Full record

ArticleCancers2026

Predictive Nomogram for Recurrence After Upfront Surgery for Resectable Pancreatic Ductal Adenocarcinoma: A Multicenter Study (OS-HBP-2).

Ryuichi Yoshida, Kosei Takagi, Kazuya Yasui, Masayoshi Hioki, Takehiro Okabayashi, Toru Kojima, Yoshikatsu Endo, Daisuke Nobuoka, Kenta Sui, Masaru Inagaki and 5 more

Abstract read
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Ryuichi YoshidaDepartment of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama 700-8558, Japan.ORCID 0000-0003-3017-7088
Kosei TakagiDepartment of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama 700-8558, Japan.ORCID 0000-0003-2267-2441
Kazuya YasuiDepartment of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama 700-8558, Japan.
Masayoshi HiokiDepartment of Surgery, Fukuyama City Hospital, Hiroshima 721-8511, Japan.
Takehiro OkabayashiDepartment of Surgery, Kochi Health Sciences Center, Kochi 781-0111, Japan.
Toru KojimaDepartment of Surgery, Okayama Saiseikai General Hospital, Okayama 700-8511, Japan.
Yoshikatsu EndoDepartment of Surgery, Himeji Red Cross Hospital, Hyogo 670-8540, Japan.
Daisuke NobuokaDepartment of Surgery, Fukuyama City Hospital, Hiroshima 721-8511, Japan.
Kenta SuiDepartment of Surgery, Kagawa Prefectural Hospital, Kagawa 760-8557, Japan.ORCID 0009-0009-5441-6005
Masaru InagakiDepartment of Surgery, National Hospital Organization Fukuyama Medical Center, Hiroshima 720-0825, Japan.ORCID 0000-0001-8049-2858
Susumu ShinouraDepartment of Surgery, Tsuyama Chuo Hospital, Okayama 708-0841, Japan.
Masashi KimuraDepartment of Surgery, Matsuyama Shimin Hospital, Ehime 790-0067, Japan.
Tatsuo MatsudaDepartment of Surgery, Tenwakai Matsuda Hospital, Okayama 710-0056, Japan.
Hideki AokiDepartment of Surgery, National Hospital Organization Iwakuni Clinical Center, Yamaguchi 740-0037, Japan.
Toshiyoshi FujiwaraDepartment of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama 700-8558, Japan.ORCID 0000-0002-5377-6051

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

nomogrampancreatic cancerrecurrenceresectableupfront surgery

Identifiers

PMID41976403
PMCPMC13072346

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.